Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.
Saved in:
| Title: | Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling. |
|---|---|
| Authors: | Plisson F; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Hill TA; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: t.hill@imb.uq.edu.au., Mitchell JM; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Hoang HN; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., de Araujo AD; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Xu W; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Cotterell A; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Edmonds DJ; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Stanton RV; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Derksen DR; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States., Loria PM; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States., Griffith DA; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Price DA; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Liras S; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Fairlie DP; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: d.fairlie@imb.uq.edu.au. |
| Source: | European journal of medicinal chemistry [Eur J Med Chem] 2017 Feb 15; Vol. 127, pp. 703-714. Date of Electronic Publication: 2016 Oct 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27823886 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Plisson+F%22">Plisson F</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Hill+TA%22">Hill TA</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: t.hill@imb.uq.edu.au.<br /><searchLink fieldCode="AU" term="%22Mitchell+JM%22">Mitchell JM</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Hoang+HN%22">Hoang HN</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22de+Araujo+AD%22">de Araujo AD</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Cotterell+A%22">Cotterell A</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Edmonds+DJ%22">Edmonds DJ</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Stanton+RV%22">Stanton RV</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Derksen+DR%22">Derksen DR</searchLink>; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States.<br /><searchLink fieldCode="AU" term="%22Loria+PM%22">Loria PM</searchLink>; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States.<br /><searchLink fieldCode="AU" term="%22Griffith+DA%22">Griffith DA</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Price+DA%22">Price DA</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Liras+S%22">Liras S</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Fairlie+DP%22">Fairlie DP</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: d.fairlie@imb.uq.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220420510%22">European journal of medicinal chemistry</searchLink> [Eur J Med Chem] 2017 Feb 15; Vol. 127, pp. 703-714. <i>Date of Electronic Publication: </i>2016 Oct 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>0420510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1768-3254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202235234%22">02235234 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27823886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejmech.2016.10.044 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 703 Titles: – TitleFull: Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Plisson F – PersonEntity: Name: NameFull: Hill TA – PersonEntity: Name: NameFull: Mitchell JM – PersonEntity: Name: NameFull: Hoang HN – PersonEntity: Name: NameFull: de Araujo AD – PersonEntity: Name: NameFull: Xu W – PersonEntity: Name: NameFull: Cotterell A – PersonEntity: Name: NameFull: Edmonds DJ – PersonEntity: Name: NameFull: Stanton RV – PersonEntity: Name: NameFull: Derksen DR – PersonEntity: Name: NameFull: Loria PM – PersonEntity: Name: NameFull: Griffith DA – PersonEntity: Name: NameFull: Price DA – PersonEntity: Name: NameFull: Liras S – PersonEntity: Name: NameFull: Fairlie DP IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 02 Text: 2017 Feb 15 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1768-3254 Numbering: – Type: volume Value: 127 Titles: – TitleFull: European journal of medicinal chemistry Type: main |
| ResultId | 1 |